Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors

Citations Over TimeTop 10% of 2012 papers

Abstract

Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) is a potent and selective allosteric inhibitor of kidney-type glutaminase (GLS) that has served as a molecular probe to determine the therapeutic potential of GLS inhibition. In an attempt to identify more potent GLS inhibitors with improved drug-like molecular properties, a series of BPTES analogs were synthesized and evaluated. Our structure-activity relationship (SAR) studies revealed that some truncated analogs retained the potency of BPTES, presenting an opportunity to improve its aqueous solubility. One of the analogs, N-(5-{2-[2-(5-amino-[1,3,4]thiadiazol-2-yl)-ethylsulfanyl]-ethyl}-[1,3,4]thiadiazol-2-yl)-2-phenyl-acetamide 6, exhibited similar potency and better solubility relative to BPTES and attenuated the growth of P493 human lymphoma B cells in vitro as well as in a mouse xenograft model.

Related Papers

• → Gold(III)-Catalyzed Selective Cyclization of Alkynyl Quinazolinone-Tethered Pyrroles: Synthesis of Fused Quinazolinone Scaffolds(2018)38 cited
• → Copper Mediated Direct Amination: Synthesis of 1,2,3,15 a‐tetrahydro‐14H‐pyrrolo[1,2‐a]quinazolino[3,2‐c]quinazolin‐14‐onederivatives via 2‐(2‐bromophenyl)quinazolin‐4(3H)‐ones(2022)2 cited
• → 2-Chloro-N-(4-chlorophenyl)acetamide(2007)7 cited
• → 2,2-Dichloro-N-(3,4-dimethylphenyl)acetamide(2009)1 cited
• → 2,2-Dichloro-N-(3,5-dimethylphenyl)acetamide(2007)1 cited